-+ 0.00%
-+ 0.00%
-+ 0.00%

Ypsomed Launches New Digitally-powered Products to Expedite Clinical Trials

MT Newswires·01/08/2026 01:21:24
Listen to the news
01:21 AM EST, 01/08/2026 (MT Newswires) -- Ypsomed (YPSN.SW) on Thursday launched new offerings that use digital solutions to expedite clinical evaluation for new therapies. The Swiss injection and infusion systems manufacturer's Clear-to-Clinic product uses pre-validated autoinjector platforms to expedite trial starts, while its CliniPilot provides automated injection data in support of studies.